Recovery Pathways

Recovery Pathways is a healthcare services provider specializing in office-based opioid treatment (OBOT) and medication-assisted treatment (MAT) for individuals with substance use disorders. Based in Western Pennsylvania, the company operates outpatient clinics that offer individualized recovery programs utilizing FDA-approved buprenorphine-based medications, such as Suboxone and Subutex. Their clinical model integrates evidence-based pharmacotherapy with comprehensive counseling and psychosocial support to address the physical and psychological aspects of addiction. In December 2020, Recovery Pathways was acquired by BayMark Health Services, the leading provider of opioid use disorder treatment in North America. This acquisition expanded BayMark's network and strengthened its office-based treatment capabilities in the Pittsburgh metropolitan area.